Supernus Pharmaceuticals (SUPN) Other financing activities (2011 - 2013)

Supernus Pharmaceuticals (SUPN) has 3 years of Other financing activities data on file, last reported at $29000.0 in Q3 2013.

• Other financing activities for Q3 2013 came in at $29000.0, up 81.25% year-over-year; the trailing twelve-month figure through Dec 2013 was $3.6 million (down 39.99% YoY), and the FY2013 annual result was $3.6 million, down 39.99% from the prior year.
• Other financing activities fell to $29000.0 in Q3 2013 per SUPN's latest filing, from $3.5 million in the prior quarter.
• Over five years, Other financing activities peaked at $3.5 million in Q2 2013 and troughed at -$2.8 million in Q3 2011.
• A 3-year average of $700363.6 and a median of $129000.0 in 2011 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2012 and 2013: Other financing activities surged 15635.71% in 2012, then plunged 81.32% in 2013.
• A 3-year view of Other financing activities shows it stood at $129000.0 in 2011, then soared by 2346.51% to $3.2 million in 2012, then sank by 99.08% to $29000.0 in 2013.
• Business Quant data shows SUPN's Other financing activities at $29000.0 in Q3 2013, $3.5 million in Q2 2013, and $125000.0 in Q1 2013.